secwatch.observer — SEC 8-K summary
======================================

Issuer:     Structure Therapeutics Inc. (GPCR)
CIK:        0001888886
Form:       8-K
Filed at:   2023-06-05T23:59:59+00:00
Accession:  0001104659-23-068028
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Structure Therapeutics dismisses PwC, engages EY as new auditor effective for FY2023
--------------------------------------------------------------------------------

- Dismissed PwC as independent auditor on May 30, 2023; PwC's reports for 2021 and 2022 were unqualified.
- Engaged EY as new independent auditor for fiscal year ending December 31, 2023, effective May 31, 2023.
- No disagreements between Company and PwC on accounting principles, audit scope, or procedures.
- Company disclosed prior material weaknesses in internal control over financial reporting (control environment, segregation of duties, ITGC).
- PwC provided letter to SEC dated June 5, 2023, agreeing with Company's statements (filed as Exhibit 16.1).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1888886/000110465923068028/0001104659-23-068028-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1888886/000110465923068028/tm2317694d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-068028

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer